Terms: = Leukemia AND PDGFRA, MGC74795, 5156, ENSG00000134853, PDGFR2, CD140A, Rhe-PDGFRA, CD140a, P16234
281 results:
1. World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.
Shomali W; Gotlib J
Am J Hematol; 2024 May; 99(5):946-968. PubMed ID: 38551368
[TBL] [Abstract] [Full Text] [Related]
2. Clinical and molecular study of radiation-induced gliomas.
Trkova K; Sumerauer D; Bubenikova A; Krskova L; Vicha A; Koblizek M; Zamecnik J; Jurasek B; Kyncl M; Malinova B; Ondrova B; Jones DTW; Sill M; Strnadova M; Stolova L; Misove A; Benes V; Zapotocky M
Sci Rep; 2024 Feb; 14(1):3118. PubMed ID: 38326438
[TBL] [Abstract] [Full Text] [Related]
3. Myeloid and lymphoid neoplasm with novel complex translocation: unusual case report with T-lymphoblastic lymphoma, myeloid hyperplasia, eosinophilia, basophilia, and t(1;8;10)( (p31;q24;q11.2).
Aljabry MS
J Hematop; 2023 Mar; 16(1):27-31. PubMed ID: 38175368
[TBL] [Abstract] [Full Text] [Related]
4. T cell phenotype and lack of eosinophilia are not uncommon in extramedullary myeloid/lymphoid neoplasms with ETV6::FLT3 fusion: a case report and review of the literature.
Schoelinck J; Gervasoni J; Guillermin Y; Beillard E; Pissaloux D; Chassagne-Clement C
Virchows Arch; 2024 May; 484(5):853-857. PubMed ID: 37985498
[TBL] [Abstract] [Full Text] [Related]
5. Integration of Genomic Sequencing Drives Therapeutic Targeting of pdgfra in T-Cell Acute Lymphoblastic leukemia/Lymphoblastic Lymphoma.
Paolino J; Dimitrov B; Apsel Winger B; Sandoval-Perez A; Rangarajan AV; Ocasio-Martinez N; Tsai HK; Li Y; Robichaud AL; Khalid D; Hatton C; Gillani R; Polonen P; Dilig A; Gotti G; Kavanagh J; Adhav AA; Gow S; Tsai J; Li Y; Ebert BL; Van Allen EM; Bledsoe J; Kim AS; Tasian SK; Cooper SL; Cooper TM; Hijiya N; Sulis ML; Shukla NN; Magee JA; Mullighan CG; Burke MJ; Luskin MR; Mar BG; Jacobson MP; Harris MH; Stegmaier K; Place AE; Pikman Y
Clin Cancer Res; 2023 Nov; 29(22):4613-4626. PubMed ID: 37725576
[TBL] [Abstract] [Full Text] [Related]
6. ROS1 Alterations as a Potential Driver of Gliomas in Infant, Pediatric, and Adult Patients.
Meredith DM; Cooley LD; Dubuc A; Morrissette J; Sussman RT; Nasrallah MP; Rathbun P; Yap KL; Wadhwani N; Bao L; Wolff DJ; Ida C; Sukhanova M; Horbinski C; Jennings LJ; Farooqi M; Gener M; Ginn K; Kam KL; Sasaki K; Kanagal-Shamanna R; Alexandrescu S; Brat D; Lu X
Mod Pathol; 2023 Nov; 36(11):100294. PubMed ID: 37532182
[TBL] [Abstract] [Full Text] [Related]
7. Myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions: reevaluation of the defining characteristics in a registry-based cohort.
Metzgeroth G; Steiner L; Naumann N; Lübke J; Kreil S; Fabarius A; Haferlach C; Haferlach T; Hofmann WK; Cross NCP; Schwaab J; Reiter A
Leukemia; 2023 Sep; 37(9):1860-1867. PubMed ID: 37454239
[TBL] [Abstract] [Full Text] [Related]
8. Dynamics of Changes in the Properties of Multipotent Mesenchymal Stromal Cells in Patients with Acute leukemia.
Sadovskaya AV; Petinati NA; Kapranov NM; Drize NI; Vasil'eva AN; Aleshina OA; Parovichnikova EN
Bull Exp Biol Med; 2023 Feb; 174(4):556-563. PubMed ID: 36894815
[TBL] [Abstract] [Full Text] [Related]
9. Diagnostic spectrum of hypereosinophilia based on bone marrow pathology: 10 years' experience at a tertiary care hospital.
Kim H; Cho YU
Int J Lab Hematol; 2023 Jun; 45(3):328-336. PubMed ID: 36756990
[TBL] [Abstract] [Full Text] [Related]
10. [FIP1L1::pdgfra-positive chronic eosinophilic leukemia showing slowly progressive cardiac impairment].
Shimizu M; Kuroda A; Suyama T; Seki M; Shinagawa A
Rinsho Ketsueki; 2022; 63(12):1648-1652. PubMed ID: 36653138
[TBL] [Abstract] [Full Text] [Related]
11. Clinical Response to Upfront Targeted Tyrosine Kinase Inhibitors among Patients with Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Gene Fusion.
Zhang Y; Nguyen L; Lu CM; Wang E; Lauw MIS; Ball S; Dong N; Moscinski L; Chan O; Yun S; Sallman D; Sokol L; Shah B; Knepper T; Lancet J; Komrokji R; Padron E; Kuykendall A; Zhang L
Clin Lymphoma Myeloma Leuk; 2023 Mar; 23(3):e150-e163. PubMed ID: 36624015
[TBL] [Abstract] [Full Text] [Related]
12. FIP1L1-pdgfra fusion gene in T-lymphoblastic lymphoma: A case report.
Ali S; Al-Qattan Y; Awny W; Hamadah A; Pinto K; AlShemmari S
Cancer Rep (Hoboken); 2023 Jan; 6(1):e1769. PubMed ID: 36517458
[TBL] [Abstract] [Full Text] [Related]
13. [FIP1L1::pdgfra-positive chronic eosinophilic leukemia presenting with multiple ulcers of oral cavity and gastrointestinal tract].
Nagamatsu K; Yanai Y; Gamachi A; Ono K
Rinsho Ketsueki; 2022; 63(11):1503-1507. PubMed ID: 36476788
[TBL] [Abstract] [Full Text] [Related]
14. Isocitrate dehydrogenase 1 mutation drives leukemogenesis by pdgfra activation due to insulator disruption in acute myeloid leukemia (AML).
Steinhäuser S; Silva P; Lenk L; Beder T; Hartmann A; Hänzelmann S; Fransecky L; Neumann M; Bastian L; Lipinski S; Richter K; Bultmann M; Hübner E; Xia S; Röllig C; Vogiatzi F; Schewe DM; Yumiceba V; Schultz K; Spielmann M; Baldus CD
Leukemia; 2023 Jan; 37(1):134-142. PubMed ID: 36411356
[TBL] [Abstract] [Full Text] [Related]
15. Two pediatric oncologic cases of hypereosinophilic syndrome and review of the literature.
Voeller J; DeNapoli T; Griffin TC
Cancer Rep (Hoboken); 2022 Nov; 5(11):e1710. PubMed ID: 36241191
[TBL] [Abstract] [Full Text] [Related]
16. Biologic therapies for hypereosinophilic disorders: From tyrosine kinase inhibitors to monoclonal antibodies. Towards an increasingly customized management?
Iurlo A; Cattaneo D
Blood Rev; 2023 Mar; 58():101014. PubMed ID: 36153195
[TBL] [Abstract] [Full Text] [Related]
17. Updates on eosinophilic disorders.
Tzankov A; Reichard KK; Hasserjian RP; Arber DA; Orazi A; Wang SA
Virchows Arch; 2023 Jan; 482(1):85-97. PubMed ID: 36068374
[TBL] [Abstract] [Full Text] [Related]
18. Fusion Gene Detection and Quantification by Asymmetric Capture Sequencing (aCAP-Seq).
Gricourt G; Tran Quang V; Cayuela JM; Boudali E; Tarfi S; Barathon Q; Daveau R; Joy C; Wagner-Ballon O; Bories D; Pautas C; Maury S; Rea D; Roy L; Sloma I
J Mol Diagn; 2022 Nov; 24(11):1113-1127. PubMed ID: 35963522
[TBL] [Abstract] [Full Text] [Related]
19. A rare cause of persistent leukocytosis with massive splenomegaly: Myeloid neoplasm with BCR-pdgfra rearrangement-Case report and literature review.
Gao L; Xu Y; Weng LC; Tian ZG
Medicine (Baltimore); 2022 Jun; 101(24):e29179. PubMed ID: 35713428
[TBL] [Abstract] [Full Text] [Related]
20. Resistance to PI3Kδ inhibitors in marginal zone lymphoma can be reverted by targeting the IL-6/pdgfra axis.
Arribas AJ; Napoli S; Cascione L; Sartori G; Barnabei L; Gaudio E; Tarantelli C; Mensah AA; Spriano F; Zucchetto A; Rossi FM; Rinaldi A; Castro de Moura M; Jovic S; Bordone-Pittau R; Di Veroli A; Stathis A; Cruciani G; Stussi G; Gattei V; Brown JR; Esteller M; Zucca E; Rossi D; Bertoni F
Haematologica; 2022 Nov; 107(11):2685-2697. PubMed ID: 35484662
[TBL] [Abstract] [Full Text] [Related]
[Next]
